Will you be at the key meeting of the year for CNS neuroscience drug development pioneers, CEOs, investors and industry leaders? See the Bio-Neuroscience Program here, and watch for additional speakers, moderators, and exciting updates! Bio-Neuroscience, the global summit of CNS neuroscience drug development leaders. 25 - 27 February. Amsterdam https://lnkd.in/eJcBGZ2t
Broadreach Global
Biotechnology Research
Accelerating Innovation. Together. The true potential of most innovation is never realized. Let's change that.
About us
Broadreach Global's mission is to accelerate breakthrough technologies to benefit human health, with a particular focus on CNS neurosciences in biopharma drug development, neurotech and neuro digital health, as well as advanced bio-manufacturing as a key field of enabling technology. Identifying world-class innovation and connecting companies with the expertise, investors and strategic partners needed to complete the value chain and translate science and engineering into meaningful impact and successful growth companies. With a unique global pipeline and network, Broadreach Global advises companies, funds, advises governments and institutions on innovation policy, and supports technology transfer offices, entrepreneurs and companies on strategy and business development.
- Website
-
https://www.broadreach-global.com/
External link for Broadreach Global
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Miami
- Type
- Privately Held
Locations
-
Primary
Get directions
Miami, US
Employees at Broadreach Global
-
Christian Suojanen
CEO / Broadreach Global, Startup Advisor, & Board Member / European Brain Foundation.
-
Rudi Komi Adigbli
On a quest to rewire the brain for optimal mental health, cognitive performance, and productivity.
-
Emi Kapetangiannis
Aspiring Neuroscientist & Innovator | Neuroscience Communications Coordinator @ Broadreach Global | Seeking Undergraduate Internships (Jun - Dec…
Updates
-
Broadreach Global reposted this
Happy New Year! Wishing all of our friends a wonderful and productive 2025. Make a New Years resolution to connect with the leading CEOs, Investors & Industry leaders in CNS Neuroscience drug development. REGISTER NOW with a 10% Special Offer using code RESOLUTION2025
-
-
Broadreach Global reposted this
Excited to share the current version of the Bio-Neuroscience 2025 Program - you've been asking for it, so here it is. Watch for additional speakers, moderators, some final updates, and most important of all, the schedule of presenting companies (coming in January) - but for now please take a look at an absolutely outstanding program of top innovators, CEOs, leading investors and industry decision-makers in CNS Neuroscience drug development. https://lnkd.in/eJcBGZ2t Bio-Neuroscience - 27 - 27 February in Amsterdam Amsterdam UMC - Amsterdam Neuroscience Beckman Coulter Life Sciences Julius Clinical Warman O'Brien Catalent Pharma Solutions Neurizon F-Prime Capital EQT Life Sciences Ysios Capital Asabys Partners M Ventures AbbVie Merck Healthcare Eli Lilly and Company Angelini Pharma UCB Ventures Lundbeck Angelini Ventures SR One Capital Management Lumira Ventures Sanofi Cima Universidad de Navarra European College of Neuropsychopharmacology (ECNP) European Brain Council Karuna Therapeutics Ipsen Denali Therapeutics Muna Therapeutics Kynexis Vandria SA MindImmune Therapeutics, Inc. Holmusk
-
Excited to share the current version of the Bio-Neuroscience 2025 Program - you've been asking for it, so here it is. Watch for additional speakers, moderators, some final updates, and most important of all, the schedule of presenting companies (coming in January) - but for now please take a look at an absolutely outstanding program of top innovators, CEOs, leading investors and industry decision-makers in CNS Neuroscience drug development. https://lnkd.in/eJcBGZ2t Bio-Neuroscience - 27 - 27 February in Amsterdam Amsterdam UMC - Amsterdam Neuroscience Beckman Coulter Life Sciences Julius Clinical Warman O'Brien Catalent Pharma Solutions Neurizon F-Prime Capital EQT Life Sciences Ysios Capital Asabys Partners M Ventures AbbVie Merck Healthcare Eli Lilly and Company Angelini Pharma UCB Ventures Lundbeck Angelini Ventures SR One Capital Management Lumira Ventures Sanofi Cima Universidad de Navarra European College of Neuropsychopharmacology (ECNP) European Brain Council Karuna Therapeutics Ipsen Denali Therapeutics Muna Therapeutics Kynexis Vandria SA MindImmune Therapeutics, Inc. Holmusk
-
Meet some of the Leading Investors speaking at Bio-Neuroscience 2025! Join your peers, pioneers and decision makers at the premier summit of global leaders in innovation, investment, and partnering in CNS Neuroscience Drug Development. https://lnkd.in/eJcBGZ2t #BioNeuroscience Sourav Kole Dolby Family Ventures Stacie Weninger F-Prime Capital Claire Leurent PhD MBA AbbVie Thomas Michael Thestrup Angelini Ventures Steven Biesmans UCB Ventures Raúl Martín-Ruiz Ysios Capital Philip Scheltens EQT Life Sciences Clara Campàs Moya Asabys Partners Hakan Goker M Ventures
-
Meet some of the CEO’s and C-Level Speakers at Bio-Neuroscience 2025! Join your peers, pioneers and decision makers at the premier summit of global leaders in innovation, investment, and partnering in CNS Neuroscience Drug Development. https://lnkd.in/eJcBGZ2t #BioNeuroscience
-
Meet leading Industry decision-makers speaking at Bio-Neuroscience 2025! Join your peers, pioneers and decision makers at the premier summit of global leaders in innovation, investment, and partnering in CNS Neuroscience Drug Development. https://lnkd.in/eJcBGZ2t #BioNeuroscience Pablo Sardi Sanofi Tarek Samad Lundbeck Jan Klatt Merck KGaA, Darmstadt, Germany Hugh Nuthall Eli Lilly and Company Nawal Roy Holmusk Jacopo Andreose Angelini Pharma Joachim Scholpp Boehringer Ingelheim Beckman Coulter Life Sciences Julius Clinical Catalent Pharma Solutions
-
REGISTER NOW - JUST 5 DAYS LEFT FOR EARLY REGISTRATION IF YOU ARE A SERIOUS STAKEHOLDER IN CNS NEUROSCIENCE DRUG DEVELOPMENT, THIS IS THE KEY INVESTMENT & PARTNERING MEETING OF THE YEAR. https://lnkd.in/eJcBGZ2t
ONE WEEK LEFT to secure your spot at the global summit of 200 of the leading CNS Neuroscience drug development pioneers, CEOs, investors and executives. Don’t miss the chance to save up to €400, and be part of Bio-Neuroscience 2025. REGISTER by 30 November 2024: https://lnkd.in/eJcBGZ2t
-
-
Meet the Keynote Speakers at Bio-Neuroscience 2025! Join your peers, pioneers and decision makers at the premier summit of global leaders in innovation, investment, and partnering in CNS Neuroscience Drug Development. https://lnkd.in/eJcBGZ2t #BioNeuroscience